Canaccord reiterates AngioDynamics stock rating on growth platforms
Covered in this story
What has happened since
- Angiodynamics Inc is up 4.3% since this was published, 13 days ago.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
Canaccord Genuity’s $20 target on $ANGO is on the record and being tracked to Oct 2027 (12-month default), scored on the close that day.
Canaccord Genuity’s track record →Call it yourself
No member calls on $ANGO yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Angiodynamics Inc →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.